These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 27236333)

  • 21. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
    Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
    Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
    Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
    Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.
    Anstadt EJ; Shumway R; Colasanto J; Grew D
    J Gastrointest Oncol; 2019 Apr; 10(2):330-338. PubMed ID: 31032102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy.
    Oymak E; Guler OC; Onal C
    Strahlenther Onkol; 2022 Mar; 198(3):247-253. PubMed ID: 34477885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
    Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
    BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Cerra-Franco A; Liu S; Azar M; Shiue K; Freije S; Hinton J; Deig CR; Edwards D; Estabrook NC; Ellsworth SG; Huang K; Diab K; Langer MP; Zellars R; Kong FM; Wan J; Lautenschlaeger T
    Clin Lung Cancer; 2019 May; 20(3):186-193.e3. PubMed ID: 30711394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of removing respiratory motion during liver SABR.
    Gargett M; Haddad C; Kneebone A; Booth JT; Hardcastle N
    Radiat Oncol; 2019 Jun; 14(1):93. PubMed ID: 31159840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
    Kavanagh BD; Schefter TE; Cardenes HR; Stieber VW; Raben D; Timmerman RD; McCarter MD; Burri S; Nedzi LA; Sawyer TE; Gaspar LE
    Acta Oncol; 2006; 45(7):848-55. PubMed ID: 16982549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
    Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience.
    Sezen D; Gurkaynak M; Gultekin M; Cengiz M; Yildiz F; Zorlu F; Akyol F; Yazici G; Hurmuz P; Ozyigit G
    Technol Cancer Res Treat; 2016 Feb; 15(1):203-11. PubMed ID: 25687510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
    Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
    BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
    Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors.
    Parker SM; Siochi RA; Wen S; Mattes MD
    Pract Radiat Oncol; 2019 Jan; 9(1):e90-e97. PubMed ID: 30267899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.
    Janoray G; Chapet S; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2014 Jun; 18(3):191-7. PubMed ID: 24837351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
    Loi M; Franceschini D; Dominici L; Chiola I; Franzese C; D'Agostino GR; Navarria P; Marzo M; Paganini L; Comito T; Mancosu P; Tomatis S; Cozzi L; Alifano M; Scorsetti M
    Strahlenther Onkol; 2021 May; 197(5):396-404. PubMed ID: 32970163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.
    Boda-Heggemann J; Jahnke A; Chan MKH; Ghaderi Ardekani LS; Hunold P; Schäfer JP; Huttenlocher S; Wurster S; Rades D; Hildebrandt G; Lohr F; Dunst J; Wenz F; Blanck O
    Strahlenther Onkol; 2018 May; 194(5):414-424. PubMed ID: 29404626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases.
    Berkovic P; Gulyban A; Defraene G; Swenen L; Dechambre D; Nguyen PV; Jansen N; Mievis C; Lovinfosse P; Janvary L; Lambrecht M; De Meerleer G
    BMC Cancer; 2020 May; 20(1):402. PubMed ID: 32384918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension.
    Anand AK; Venkadamanickam G; Punnakal AU; Walia BS; Kumar A; Bansal AK; Singh HM
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):345-52. PubMed ID: 25726363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.